Komal AgarwalNovember 17, 202610.5281/zenodo.24321668pp. 582–5887 pages
PDF preview
In State of Kerala v. M/s Panacea Biotec Ltd., the Supreme Court restored a prosecution for misbranding a pentavalent vaccine under the Drugs and Cosmetics Act, 1940, which the Kerala High Court had quashed because the Magistrate did not hold the inquiry required by section 202 of the Code of Criminal Procedure, 1973. The Court held that limitation under section 469(1)(c) runs from the date on which the offenders' identity is established through the inspector's verification, and that a complaint by a public servant in discharge of official duty is not vitiated by want of a section 202 inquiry. It also held that whether directors are in charge of a company under section 34 of the Drugs Act is a question of fact for trial. This comment argues that the reasoning on limitation sits uneasily with the offender specific wording of section 469, that reading section 200 into section 202 conflates two different safeguards, and that substituting accused persons twenty years after the events raises fairness questions the Court left unexamined.
References are included in the full PDF.
Access the full PDF, export a citation, or submit your own research to IJLJ.